X4 PHARMACEUTICALS, INC (XFOR) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading XFOR…

X4 PHARMACEUTICALS, INC (XFOR) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

X4 PHARMACEUTICALS, INC

XFOR · CIK 1501697

4 · Oct 5, 2026 · Chief Financial Officer KIRSKE DAVID sold 11.77K shares at $2.86/share ($33,658)

4

Chief Financial Officer KIRSKE DAVID sold 11.77K shares at $2.86/share ($33,658)

Filed: Oct 5, 2026
Period: Oct 1, 2026
Accession: 0001501697-26-000078
Filer: X4 Pharmaceuticals, Inc

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1791230611.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1791230611.xml
Open SEC.gov